ACLY and metabolic dysfunction-associated steatotic liver disease: As illustrated in our proposed metabolic model (Figure 6), ACLY may thus serve as a central metabolic node that integrates carbohydrate overload with increased hepatic glucose output, providing a biochemical basis for the metabolic paradox observed in NAFLD and T2DM.